Drug recall · June 29, 2022
Clonidine Transdermal System recall
Why: Defective Delivery System: Out of specification for release liner removal force results at the 3-month CRT stability timepoint.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Clonidine Transdermal System, USP 0.3 mg/day, 4 Patches (NDC 51862-455-01) per Carton (51862-455-04), Rx only, Manufactured for: Mayne Pharma Greenville, NC 27834
- Lots / codes
Lot: 41179A Exp. Jan 2023
- Quantity
- 1440 cartons
- Company
- Mayne Pharma Inc, Greenville, NC
- Distribution
- Nationwide in the US Market
- Initiated
- June 9, 2022 · Voluntary: Firm initiated
- Classified
- June 21, 2022
- Reported
- June 29, 2022
- Ended
- August 23, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Clonidine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.